Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis

2.

Sung

L

,

Aplenc

R

,

Alonzo

TA

,

Gerbing

RB

,

Gamis

AS

;

AAML0531/PHIS Group

.

Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children’s Oncology Group

.

Haematologica

.

2012

;

97

(

11

):

1770

-

1773

.

3.

Porcu

P

,

Cripe

LD

,

Ng

EW

, et al.

Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management

.

Leuk Lymphoma

.

2000

;

39

(

1-2

):

1

-

18

.

4.

Porcu

P

,

Farag

S

,

Marcucci

G

,

Cataland

SR

,

Kennedy

MS

,

Bissell

M

.

Leukocytoreduction for acute leukemia

.

Ther Apher

.

2002

;

6

(

1

):

15

-

23

.

5.

Aqui

N

,

O'Doherty

U

.

Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia

.

Hematology Am Soc Hematol Educ Program

.

2014

;

2014

(

1

):

457

-

460

.

6.

Stahl

M

,

Pine

A

,

Hendrickson

JE

, et al.

Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey

.

Leuk Lymphoma

.

2018

;

59

(

11

):

2723

-

2726

.

7.

Rowe

JM

,

Lichtman

MA

.

Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia

.

Blood

.

1984

;

63

(

5

):

1230

-

1234

.

8.

Lichtman

MA

,

Rowe

JM

.

Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations

.

Blood

.

1982

;

60

(

2

):

279

-

283

.

9.

Azoulay

E

,

Fieux

F

,

Moreau

D

, et al.

Acute monocytic leukemia presenting as acute respiratory failure

.

Am J Respir Crit Care Med

.

2003

;

167

(

10

):

1329

-

1333

.

10.

Cuttner

J

,

Conjalka

MS

,

Reilly

M

, et al.

Association of monocytic leukemia in patients with extreme leukocytosis

.

Am J Med

.

1980

;

69

(

4

):

555

-

558

.

11.

Lester

TJ

,

Johnson

JW

,

Cuttner

J

.

Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis

.

Am J Med

.

1985

;

79

(

1

):

43

-

48

.

12.

Lichtman

MA

.

Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations

.

J Clin Invest

.

1973

;

52

(

2

):

350

-

358

.

13.

Lichtman

MA

,

Weed

RI

.

Peripheral cytoplasmic characteristics of leukocytes in monocytic leukemia: relationship to clinical manifestations

.

Blood

.

1972

;

40

(

1

):

52

-

61

.

14.

Rinaldi

I

,

Sari

RM

,

Tedhy

VU

,

Winston

K

.

Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients—a dual-center retrospective cohort study

.

J Blood Med

.

2021

;

12

:

623

-

633

.

15.

Rinaldi

I

,

Sutandyo

N

,

Winston

K

.

Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis

.

Hematology

.

2022

;

27

(

1

):

141

-

149

.

16.

Bewersdorf

JP

,

Giri

S

,

Tallman

MS

,

Zeidan

AM

,

Stahl

M

.

Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—a systematic review and meta-analysis

.

Transfusion

.

2020

;

60

(

10

):

2360

-

2369

.

17.

Chang

MC

,

Chen

TY

,

Tang

JL

, et al.

Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage

.

Am J Hematol

.

2007

;

82

(

11

):

976

-

980

.

18.

Choi

MH

,

Choe

YH

,

Park

Y

, et al.

The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study

.

Transfusion

.

2018

;

58

(

1

):

208

-

216

.

19.

Malkan

UY

,

Ozcebe

OI

.

Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis

.

Transfus Apher Sci

.

2017

;

56

(

6

):

880

-

882

.

20.

Oberoi

S

,

Lehrnbecher

T

,

Phillips

B

, et al.

Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis

.

Leuk Res

.

2014

;

38

(

4

):

460

-

468

.

21.

Porcu

P

,

Danielson

CF

,

Orazi

A

,

Heerema

NA

,

Gabig

TG

,

McCarthy

LJ

.

Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate

.

Br J Haematol

.

1997

;

98

(

2

):

433

-

436

.

22.

Shallis

RM

,

Stahl

M

,

Bewersdorf

JP

,

Hendrickson

JE

,

Zeidan

AM

.

Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits

.

Expert Rev Hematol

.

2020

;

13

(

5

):

489

-

499

.

23.

Stahl

M

,

Shallis

RM

,

Wei

W

, et al.

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

.

Leukemia

.

2020

;

34

(

12

):

3149

-

3160

.

24.

Connelly-Smith

L

,

Alquist

CR

,

Aqui

NA

, et al.

Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue

.

J Clin Apher

.

2023

;

38

(

2

):

77

-

278

.

25.

Marbello

L

,

Ricci

F

,

Nosari

AM

, et al.

Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature

.

Leuk Res

.

2008

;

32

(

8

):

1221

-

1227

.